Matthew M. Ames, PhD | Authors

CLEBURNE DRUG INC

501 N RIDGEWAY DR

Articles

Endocrine Therapy in 2009: Consideration of the Tumor and the Host

February 18, 2009

Breast cancer is the most common female malignancy in the Western world. Two-thirds of all breast cancers are estrogen receptor (ER)-positive, a phenotypic characteristic that is prognostic of disease-free survival and predictive of response to endocrine therapy.